| Daniel Patrick Herring, PT, DPT, SCS | |
|
530 Shadows Ln, Baton Rouge, LA 70806-6530 | |
| (225) 927-9185 | |
| (225) 231-3803 |
| Full Name | Daniel Patrick Herring |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist - Sports |
| Location | 530 Shadows Ln, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093066029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251S0007X | Physical Therapist - Sports | 08312 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Patrick Herring, PT, DPT, SCS 530 Shadows Ln, Baton Rouge, LA 70806-6530 Ph: (225) 927-9185 | Daniel Patrick Herring, PT, DPT, SCS 530 Shadows Ln, Baton Rouge, LA 70806-6530 Ph: (225) 927-9185 |
News Archive
DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.
Researchers at the NFCR Center for Cancer System Informatics at MD Anderson Cancer Center have discovered a key factor that may explain drug resistance in glioblastoma (GBM), the most common and deadliest form of brain cancer.
Since 2002, the number of new-born babies who have suffered a violent death has more than halved in Austria. This encouraging development is due to the introduction of the Anonymous Birth scheme in 2001. Scientists at the MedUni Vienna have now been able to provide proof of the scheme's effectiveness.
American Vanguard Corporation, today announced financial results for the third quarter and nine month period ended September 30, 2011.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
› Verified 3 days ago
Ms. Victoria P Zaunbrecher, PT, DPT, OCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13702 Coursey Blvd Ste 10b, Baton Rouge, LA 70817 Phone: 225-364-3915 | |
Mrs. Kelly Quebedeaux, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1050 S Foster Dr, Baton Rouge, LA 70806 Phone: 504-912-7807 | |
Dutch Physical Therapy, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 5627 Bankers Ave., Baton Rouge, LA 70808 Phone: 225-927-3000 Fax: 225-927-4183 | |
Neurotherapy Specialists Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11140 N Harrells Ferry Rd, Baton Rouge, LA 70816 Phone: 225-272-0150 Fax: 225-275-0930 | |
Kinta Leblanc, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7850 Anselmo Ln, Baton Rouge, LA 70810 Phone: 225-768-6417 | |
Mrs. Erin Wright, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3022 Gilbert Dr, Baton Rouge, LA 70809 Phone: 225-937-6150 | |
Industrial Center Of Baton Rouge Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 16645 Highland Rd Ste L, Baton Rouge, LA 70810 Phone: 225-756-2722 Fax: 225-756-4431 |